Vident Advisory’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.38M Sell
148,830
-5,071
-3% -$218K 0.05% 287
2025
Q4
$6.75M Buy
153,901
+3,085
+2% +$128K 0.06% 254
2025
Q3
$6.23M Sell
150,816
-18,573
-11% -$747K 0.06% 261
2025
Q2
$7.47M Sell
169,389
-109,474
-39% -$4.38M 0.08% 201
2025
Q1
$10.3M Buy
278,863
+122,989
+79% +$4.38M 0.15% 133
2024
Q4
$5.19M Buy
155,874
+36,850
+31% +$1.2M 0.09% 201
2024
Q3
$3.09M Buy
+119,024
New +$2.96M 0.08% 269

Other funds holding EXEL

Vident Advisory's EXEL Position: Q1 2026 in Review

Vident Advisory reduced its Exelixis (EXEL) stake by 3.3% in Q1 2026, selling an estimated $218K and leaving 148,830 shares worth $6.38M. The position accounts for 0.05% of the portfolio, ranked #287.

Vident Advisory first reported a position in EXEL in Q3 2024 and has held it in 7 quarters since. The position peaked at $10.3M in Q1 2025. 694 funds tracked by Wall St. Rank hold EXEL as of Q1 2026.

  • Vident Advisory held 148,830 shares of Exelixis worth $6.38M as of Q1 2026.
  • Vident Advisory sold 5,071 Exelixis shares in Q1 2026, an estimated $218K.
  • Exelixis made up 0.05% of Vident Advisory's portfolio in Q1 2026, its #287 holding.
  • Vident Advisory first reported a position in Exelixis in Q3 2024 and has held it in 7 quarters since.
  • Vident Advisory's Exelixis position peaked at $10.3M in Q1 2025.
  • 694 funds tracked by Wall St. Rank held Exelixis as of Q1 2026.

Based on Vident Advisory's 13F filing for Q1 2026, filed 15 May 2026.